Meeder Advisory Services’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Buy
4,060
+73
+2% +$8.84K 0.02% 463
2026
Q1
$652K Sell
3,987
-795
-17% -$122K 0.03% 342
2025
Q4
$832K Buy
4,782
+570
+14% +$104K 0.04% 303
2025
Q3
$607K Buy
4,212
+337
+9% +$41.3K 0.03% 353
2025
Q2
$390K Buy
3,875
+368
+10% +$28.1K 0.02% 430
2025
Q1
$268K Sell
3,507
-40
-1% -$3.06K 0.02% 482
2024
Q4
$245K Sell
3,547
-72
-2% -$5.18K 0.02% 492
2024
Q3
$264K Buy
3,619
+108
+3% +$7.97K 0.02% 465
2024
Q2
$235K Buy
+3,511
New +$136K 0.02% 457

Other funds holding INSM

Meeder Advisory Services's INSM Position: Q2 2026 in Review

Meeder Advisory Services increased its Insmed (INSM) stake by 1.8% in Q2 2026, buying an estimated $8.84K and bringing the position to 4,060 shares worth $433K. The position accounts for 0.02% of the portfolio, ranked #463.

Meeder Advisory Services first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $832K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Meeder Advisory Services held 4,060 shares of Insmed worth $433K as of Q2 2026.
  • Meeder Advisory Services bought 73 Insmed shares in Q2 2026, an estimated $8.84K.
  • Insmed made up 0.02% of Meeder Advisory Services's portfolio in Q2 2026, its #463 holding.
  • Meeder Advisory Services first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Meeder Advisory Services's Insmed position peaked at $832K in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.